TABLE 1.
Summary of the study populationa
| Parameter (unit) | Median (range), n = 30 |
|---|---|
| Age (yr) | 53 (28–76) |
| Wt (kg) | 74 (40–150) |
| Ht (cm) | 171 (156–185) |
| No. of subjects | |
| Male/female | 16/14 |
| CRRT (yes/no) | 21/9 |
| ECMO (yes/no) | 10/20 |
| Survival (yes/no) | 13/17 |
| Liver failure (yes/no) | 3/27 |
| SOFA score | 11.0 (2.00–19.0) |
| PCT concn (μmol/liter) | 3.72 (0.130–85.0) |
| Dialysis dose (liter/h) | 2.00 (1.34–3.00) |
| Ultrafiltration rate (liter/h) | 0.09 (0.03–0.30) |
| ELWI | 9.00 (5.50–37.0) |
| Cardiac output (liter) | 6.22 (1.84–14.4) |
| Albumin concn (g/dl) | 2.00 (0.80–3.30) |
| Total serum protein concn (g/dl) | 4.68 (2.67–6.06) |
a
Values are expressed as the median and range (except as indicated otherwise in column 1) for continuous covariates and as counted for categorical variables. CRRT, continuous renal replacement therapy; ECMO, extracorporeal membrane oxygenation; SOFA, sequential organ failure assessment score; PCT, procalcitonin; ELWI, extravascular lung water index.